Inventor · disambiguated record
Xi Wang
Also filed as: WANG XI · WANG XI-DE
1 granted patent·12 pending applications·0 citations·filing 2005–2024
10Inventor score
Files withUNIV CALIFORNIA4APPIA BIO INC3CHEN FENG2BRISTOL MYERS SQUIBB CO1GAN & LEE PHARMACEUTICALS CO LTD1
Top patents by PatentIndex Score
13 records- 0167US2025170184A1Engineered immunomodulatory accessory cells improve allogeneic islet transplantation without immunosuppressionUNIV CORNELL·Filed 2023·Application pending·0 cites
- 0266US2025188498A1Genetically modified pseudomonas host cells and methods useful for producing isoprenolUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 0360US2023124097A1Engineering stem cell t cells with multiple t cell receptorsAPPIA BIO INC·Filed 2022·Application pending·0 cites
- 0459US11939618B2Fusion proteins useful for modifying terpenesUNIV CALIFORNIA·Filed 2021·Granted Mar 26, 2024·0 cites·22 claims
- 0558US2023391871A1Monoamine oxidase blockade therapy for treating cancer through regulating tumor associated macrophages (tams)UNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 0658US2023390220A1Monoamine oxidase blockade therapy for treating cancer through regulating antitumor t cell immunityUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 0758US2024240148A1Engineering stem cells for allogenic car t cell therapiesAPPIA BIO INC·Filed 2022·Application pending·0 cites
- 0856US2024271095A1Production of engineered t cells from stem cellsAPPIA BIO INC·Filed 2022·Application pending·0 cites
- 0953US2008241967A1Radioimmunoassay using nanoparticle-antibody conjugatesCHEN FENG·Filed 2008·Application pending·0 cites
- 1047US2024316157A1Pharmaceutical composition of pcsk9 inhibitor and glp-1 receptor agonistGAN & LEE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1145US2006099721A1Radioimmunoassay using nanoparticle-antibody conjugatesCHEN FENG·Filed 2005·Application pending·0 cites
- 1241US2010120788A1Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in prostate cellsBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 1330US2011045053A1Isolated population of luminal stem cells that give rise to prostate cancer and methods of using sameSHEN MICHAEL M·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xi Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →